INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2016

Distal, but not proximal, colonic acetate infusions increased fasting fat oxidation and PYY in overweight or obese men.

Six overweight/obese men underwent two experimental periods with endoscopically placed catheters for distal and proximal colonic infusions of sodium acetate (100 or 180 mmol/l) or placebo across fasting and postprandial conditions. Distal colonic 180 mmol/l acetate infusions significantly increased fasting fat oxidation (1.78±0.28 vs. -0.78±0.89 g fat 2 h-1, P=0.015), fasting PYY (P=0.01), and postprandial glucose and insulin levels (P<0.05) compared to placebo. Distal 100 mmol/l acetate tended to decrease fasting TNF-α (P=0.067). In contrast, proximal colonic acetate infusions had no observed effects on substrate metabolism, circulating hormones, or inflammatory markers.

Study type
Randomized, double-blind crossover trial
Who was studied
6 overweight/obese men (BMI 25-35 kg/m2)
What was measured
Fat oxidation, energy expenditure, circulating hormones, and inflammatory markers

THE PAPER

Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men.

van der Beek CM, Canfora EE, Lenaerts K, Troost FJ, Damink SWMO, Holst JJ, Masclee AAM, Dejong CHC, Blaak EE. Clin Sci (Lond), 2016.

PubMed 27439969 ↗DOI 10.1042/cs20160263 ↗

Gut & microbiomeNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.